Mostrar el registro sencillo del ítem

dc.contributor.advisorJaramillo Botero, Nataliaspa
dc.contributor.advisorMantilla Suárez, Juan Carlosspa
dc.contributor.advisorRey Serrano, Juan Joséspa
dc.contributor.authorPabón Romero, Juan Carlosspa
dc.contributor.authorVilla Velásquez, Hoovermanspa
dc.date.accessioned2020-06-26T20:07:18Z
dc.date.available2020-06-26T20:07:18Z
dc.date.issued2006
dc.identifier.urihttp://hdl.handle.net/20.500.12749/1861
dc.description.abstractEl cáncer de mama es el tumor invasivo más frecuente en mujeres, con más de un millón de casos y cerca de 600000 muertes al año en todo el mundo , con tasas de incidencia más altas en países industrializados, como Estados Unidos, Australia y países de Europa Occidental, que pueden estar relacionadas con mudanzas en los patrones reproductivos así como una mayor uso de la mamografía2 3 4 5 . La tasa de incidencia no es igual para todos los grupos raciales y étnicos, lo que refleja los diversos grados de desarrollo socioeconómico y características culturales . La mamografía es el único método de tamizaje que ha demostrado reducción en la tasa de mortalidad debida a cáncer de mama, y en la revisión de 8 estudios controlados randomizados de mamografía y 2 de autoexamen, realizada por Jatoi,se evidenció una reducción de 22% en la tasa de mortalidad por cáncer de mama en mujeres de 50 años de edad o más, durante 14 años de observación, y de 15% en mujeres entre 40 y 49 años de edad. La disminución en las tasas de mortalidad fue casi totalmente atribuible a la reducción de la distribución del tamaño de cánceres detectados a través de la mamografía de tamizaje8 . El propósito principal de la mamografía es detectar el cáncer precozmente, cuando es pequeño, con ganglios negativos y requiere un tratamiento menos intenso y tiene un mejor pronóstico.spa
dc.description.tableofcontents1. Planteamiento del problema 2. Objetivos 3. Marco teórico a. Epidemiología i. Frecuencia ii. Factores de riesgo b. Tamizaje mamográfico c. Ecografía mamaria 4. Metodología a. Tipo de estudio b. Universo y muestra c. Métodos e instrumentos d. Técnicas y procedimientos 5. Resultados a. Análisis univariado b. Análisis bivariado 6. Discusión 7. Conclusiones 8. Recomendaciones 9. Bibliografíaspa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleHallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004spa
dc.title.translatedMammographic and ultrasound findings from 10,000 studies performed in the radiology service of La Foscal between January 1998 and June 2004eng
dc.degree.nameEspecialista en Radiología e Imágenes Diagnósticasspa
dc.coverageBucaramanga (Santander, Colombia)spa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programEspecialización en Radiología e Imágenes Diagnósticasspa
dc.description.degreelevelEspecializaciónspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.localTesisspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.subject.keywordsRadiodiagnosiseng
dc.subject.keywordsMammographyeng
dc.subject.keywordsMedicineeng
dc.subject.keywordsRadiologyeng
dc.subject.keywordsDiagnostic imageseng
dc.subject.keywordsDiagnostic imagingeng
dc.subject.keywordsX-rayseng
dc.subject.keywordsInvestigationseng
dc.subject.keywordsAnalysiseng
dc.subject.keywordsTumoreng
dc.subject.keywordsIndustrialized countrieseng
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.relation.referencesPabón Romero, Juan Carlos, Villa Velásquez, Hooverman, Mantilla Suárez, Juan Carlos (2006). Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio de 2004. Bucaramanga (Colombia) : Universidad Autónoma de Bucaramanga UNABspa
dc.relation.referencesIARC, WHO. Breast cancer, in Stewart B, Kleihues P (eds). World Cancer Report. Lyon: IARC Press, 2003; 188–19.spa
dc.relation.referencesArmstrong B. Recent trends in breast-cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer. 1976;17(2):204-211.spa
dc.relation.referencesFlaws, J. A., Bush, T. L., Newschaffer, C. J., Chu, K. C., Tarone, R. E., Brawley, O. W. (2000). Racial Differences in Breast Cancer Mortality. Arch Fam Med 9: 412-413spa
dc.relation.referencesRies L, Eisner M, Kosary M. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002.spa
dc.relation.referencesMiller B, Feuer E, Hankey B. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993; 43: 27–41Cancer 1994; 74: 222–227.spa
dc.relation.referencesNCI Cancer Surveillance Monograph Series, Number 4. Bethesda (MD): nacional Cancer Institute, 2003.spa
dc.relation.referencesJatoi I. Breast cancer screening. Am J Surg, 1999; 177(6):518-24).spa
dc.relation.referencesFarria DM, Monses B. Screening mammography practice Essentials. Radiol Clin N Am 42 (2004) 831-843spa
dc.relation.referencesAmerican College of Radiology. Breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003.spa
dc.relation.referencesChu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996; 88:1571-1579.spa
dc.relation.referencesGhafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003; 53(6):342-355.spa
dc.relation.referencesHamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep 2003; 51(12):1-94.spa
dc.relation.referencesBrett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145(6):536-545.spa
dc.relation.referencesHealth, United States, 2002 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics, 2002.spa
dc.relation.referencesSchwartsmann G Journal of clinical oncology, vol 19, #18s (sept 15 supplement<9, 2001: pp 118s-124s.spa
dc.relation.referencesCarrascal E. Registro poblacional de cáncer de Cali. Universidad del Valle - Cali - Colombia, editor. 1995. Cali: Departamento de Patología -Facultad de Salud.Programa de Investigación de Cáncer de Cali.spa
dc.relation.referencesRegistro poblacional de cáncer del área metropolitana de Bucaramanga 2000-2003 Proyecto de investigación Universidad Autónoma de Bucaramanga-Instituto Nacional de Cancerología.spa
dc.relation.referencesMiller AB, To T, Wall C. Canadian national breast screening study: 1: breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76.spa
dc.relation.referencesRomero J, Burbano R, Angarita M. Recomendaciones actuales para el tamizaje de cáncer de seno según la evidencia medica. Rev Col Cirugía, 2003;18:51-59.spa
dc.relation.referencesFalkenberry S, Legare R. Risk factors for breast cancer. Obst and Gyn Clin of N Am; 2002:29: 159-172.spa
dc.relation.referencesAhmedin Jemal, Taylor Murray, Elizabeth Ward, Alicia Samuels, Ram C. Tiwari, Asma Ghafoor, Eric J. Feuer and Michael J. Cancer Statistics, 2005 Thun CA Cancer J Clin 2005;55;10 30spa
dc.relation.referencesGeorge H Perkins and Lavinia P Middleton Breast cancer in men 2003;327;239-240 BMJspa
dc.relation.referencesBland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73.spa
dc.relation.referencesRayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, et al. Molecular markers in male breast carcinoma. Cancer 1998;83:1947-55.spa
dc.relation.referencesScott-Conner CH, Jochimsen PR, Menck HR, Winchester DJ. Ann analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;125:775-81.spa
dc.relation.referencesShoker BS, Jarvis C, Sibson DR,Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999;188:237-44.spa
dc.relation.referencesFriedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al. Mutation analysis of BRCA 1 and BRCA 2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.m J Hum Genet 1997;60:313-9.spa
dc.relation.referencesBland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73.spa
dc.relation.referencesScott-Conner CH, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;125:775-81.spa
dc.relation.referencesAmir H, Makwaya CK, Moshiro C, Kwesigabo G. Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J. 1996;73:187-90.spa
dc.relation.referencesGiordano SH; Buzdar AU and Hortobagyi GN. Breast Cancer in Men. Ann Intern Med. 2002;137:678-687.spa
dc.relation.referencesThomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135:734-48.spa
dc.relation.referencesHultborn R, Hanson C, Ko¨pf I, Verbiene´ I, Warnhammar E, Weimarck A. Prevalence of Klinefelter’s syndrome in male breast cancer patients. Anticancer Res. 1997;17:4293-7.spa
dc.relation.referencesvan Geel AN, van Slooten EA, Mavrunac M, Hart AA. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724-7.spa
dc.relation.referencesLandis SH, Murria T, Bolden S et al. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-29.spa
dc.relation.referencesRies LAG, Miller BA, Hankey BF et al (eds). SEER Cancer Statistics Review, 1973 1991:Tables and Graphs. NIH publication number 94 2789. Bethesda, MD, US Department of Health and Human Services, National Cancer Institute, 1994.spa
dc.relation.referencesParkin DM, Whelan SL, Ferlay J, Storm H: Cancer Incidence in Five Continents Vol.VIII. International Agency for research on Cancer [IARC], Lyon, France, IARC Scientific Publication No. 155. 2002.spa
dc.relation.referencesSaxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G,Goldgar DE, Bhatanagar D: BRCA1 and BRCA2 in Indian BreastCancer patients. Hum Mut 2002, 20:473-474.spa
dc.relation.referencesBecher H, Schmidt S and Chang-Claude J. Reproductive factors and familial predisposition for breast cancer by age 50 years. A case-control-family study for assesing main effects and possible gene-environment interaction. Int J Epidemiol 2003;32:38-48spa
dc.relation.referencesClaus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651.spa
dc.relation.referencesMiki Y, Swensen J, Shattuck-Eidens D. et al. Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71.spa
dc.relation.referencesWooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378(21/28):789–792.spa
dc.relation.referencesEaston DF, Steele L, Fields P, et al: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120–128.spa
dc.relation.referencesVerhoog L, Brekelmans C, Seynaeve C et al. Survival and tumor characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;351:316–321.spa
dc.relation.referencesMarcus J, Watson P, Page D et al. Hereditary breast cancer: Pathobiology, prognosis,and BRCA1 and BRCA2 linkage. Cancer 1996;77:697–709.spa
dc.relation.referencesClaus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961–72.spa
dc.relation.referencesClaus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651.spa
dc.relation.referencesPeto J. Genetic predisposition to cancer. In: Cairns J, Lyon JL, Skolnik M,editors. Cancer incidence in defined populations. Banbury Report No. 4. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1980. p. 203–13.spa
dc.relation.referencesSaxena S, Rekhi B, Bansal A, Bagga A, Ch and S Murthy N. Clinico-morphological patterns of breast cancer ncluding family history in a New Delhi hospital, India-A cross-sectional study World Journal of Surgical Oncology 2005, 3:67.spa
dc.relation.referencesChen Y, Thompson W, Semenciw R,Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarker Prev. 1999;8:855-861.spa
dc.relation.referencesHealy E, Cook E, Orav E, Schnitt S, Connolly J, Harris J. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545-1552.spa
dc.relation.referencesBernstein JL, Laponski RH, Thakore SS, Doucette JT, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology 2003;14:552-558.spa
dc.relation.referencesOttman R, Pike MC, King MC, Henderson BE. Practical guide for stimating risk for familial breast cancer. Lancet. 1983;2(8349):556-558.spa
dc.relation.referencesMandelson MT, Oestreicher N, Porter PL et al. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081–1087.spa
dc.relation.referencesZiv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic Breast Density and Family History of Breast Cancer. Journal of the National Cancer Institute, Vol. 95, No. 7, April 2, 2003.spa
dc.relation.referencesLove SM, Gelman RS, Silen W. Fibrocystic ‘‘disease’’ of the breast—a nondisease? N Engl J Med 1982;307:1010–1014.spa
dc.relation.referencesPage DL, Dupont WD, Jensen RA. Papillary apocrine change of the breast associated with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1996;5:29–32.spa
dc.relation.referencesPage DL, Vander Zwaag R, Rogers LW et al. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978;61:1055–1063.spa
dc.relation.referencesBerg WA, Campassi CI, Ioffe OB. Cystic Lesions of the Breast: Sonographic-Pathologic Correlation. Radiology 2003; 227:183–191.spa
dc.relation.referencesKelsey JL. Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993:15;36-47.spa
dc.relation.referencesMacMahon B. Reproduction and cancer of the breast. Cancer 1993;71:3185-3188.spa
dc.relation.referencesMacMahon B, Cole P Lin TM et al. Age at first birth and breast cancer risk. World Health.spa
dc.relation.referencesJanjan N X, Wilson JF, Gillin M, et al. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 1988;61:252-254.spa
dc.relation.referencesBhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751.spa
dc.relation.referencesLambe M, Hsich C-C, Trichopoulos D et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5–9.spa
dc.relation.referencesWohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology 2001;12:68–73.spa
dc.relation.referencesChie WC, Hsieh C, Newcomb PA et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 2000;151:715–722.spa
dc.relation.referencesBernier MO, Plu-Bureau G, Bossard N. Breastfeeding and risk of breast cancer: A meta analisys of publuished studies. Hum Reprod Update 2000; 6: 374-386.spa
dc.relation.referencesZheng T, Holford TR, Mayne ST et al. Lactation and breast cancer risk: A case control study in Connecticut. Br J Cancer 2001;84:1472-1476.spa
dc.relation.referencesTorgerson DJ, Bell-Syer SE: Hormone replacement therapy and prevention of nonvertebral fractures. JAMA 2001285:2891–2897.spa
dc.relation.referencesGrodstein F, Stampfer MJ, Colditz GA et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769–1775.spa
dc.relation.referencesBeral V, Bull D, Doll R et al. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047–1059.spa
dc.relation.referencesColditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurses’ Health Study. Am J Epidemiol 2000;152: 950–964.spa
dc.relation.referencesHofseth LJ, Raafat AM, Osuch JR et al. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999;84:4559–4565.spa
dc.relation.referencesRoss RK, Paganini-Hill A, Wan PC et al. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328–332.spa
dc.relation.referencesSchairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485–491.spa
dc.relation.referencesPsaty BM, Smith NL, Lemaitre RN et al. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA 2001285:906–913.spa
dc.relation.referencesSpinler SA, Hilleman DE, Cheng JW et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001;35:589–617.spa
dc.relation.referencesSilvera SA, Miller AB, Rohan TE. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control. 2005 Nov;16(9):1059-63.spa
dc.relation.referencesMuti P, Trevisan M, Micheli A et al. Alcohol consumption and total estradiol in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:189–191.spa
dc.relation.referencesDorgan JF, Baer DJ, Albert PS et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710–715.spa
dc.relation.referencesLash TL, Aschengrau A. Alcohol drinking and risk of breast cancer. The Breast Journal 2000;6:396–399.spa
dc.relation.referencesSmith-Warner SA, Spiegelman D, Yaun SS et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 1998;279:535–540.spa
dc.relation.referencesCouch FJ, Cerhan JR, Vierkant RA, et al: Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10: 327–332, 2001.spa
dc.relation.referencesLee IM, Rexrode KM, Cook NR et al. Physical activity and breast cancer risk: The Women’s Health Study (United States). Cancer Causes Control 2001;12:137–145.spa
dc.relation.referencesMatthews CE, Shu XO, Jin F et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 2001;84:994–1001.spa
dc.relation.referencesClark RA. Principles of cancer screening. Cancer Control 1995;2:485-92.spa
dc.relation.referencesClark RA, Reintgen DS. Principles of cancer screening. In: Reintgen DS, editors. Cancer screening. St Louis (MO): Mosby; 1996. 1-22.spa
dc.relation.referencesEddy DM. Common screening tests. Philadelphia: American College of Physicians; 1991.spa
dc.relation.referencesGrimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4.spa
dc.relation.referencesClark R. Principles of cancer screening. Radiol Clin N Am 42 (2004) 735-746.spa
dc.relation.referencesMoskowitz M. Screening is not diagnosis. Radiology 1979;133:265-8.spa
dc.relation.referencesAmerican Cancer Society. Breast cancer facts & figures 2003-2004. Atlanta (GA) : American Cancer Society; 2004.spa
dc.relation.referencesBassett LW, Hendrick RE, Bassford TL, Butler PF, Cater D, DeBor M, et al. Quality determinants of mammography. Rockville (MD): Agency for health Policy and research, Public Health Service, US department of Health and Human Services;1994. Clinical Practice Guideline #3. AHCPR Publication #95-0632.spa
dc.relation.referencesShapiro S, Venet W, Strax P, Venet L, Roeser R. 10 to 14 years effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.spa
dc.relation.referencesNystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973-8.spa
dc.relation.referencesRoberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forrest P, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-6.spa
dc.relation.referencesMiller AB, To T, Wall C. Canadian national breast screening study: 1: breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76.spa
dc.relation.referencesMiller AB, To T, Wall C. Canadian national breast screening study: 2: breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992;147:1477-88.spa
dc.relation.referencesKerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-54.spa
dc.relation.referencesChang HR, Cole B, Bland KI. Nonpalpable brest cancer in women aged 40-49 years: a surgeon’s view of benefits from screening mammography. Monogr Natl Cancer Inst 1997;22:145-9.spa
dc.relation.referencesYokoe T, Iino Y, Maemura M, Takei H, Horiguchi J, Matsumoto H, et al. Efficacy of mammography for detecting early breast cancer in women Ander 50. Anticancer Res 1998;18:4709-12.spa
dc.relation.referencesGotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.spa
dc.relation.referencesOlsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2.spa
dc.relation.referencesNCI statement on mammography screening. Office of Communications/Mass Media Branch. Bethesda, MD: National Institutes of Health; February 21, 2002.spa
dc.relation.referencesLee CH. Screening mammography: proven benefit, continued controversy. Radiol Clin N Am 40 (2002) 395-497.spa
dc.relation.referencesHuynh PT, Jarolimek AM, Daye S. The false-negative mammogram. Radiographics 1998;18:1137-54spa
dc.relation.referencesMoskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986;161:37-41.spa
dc.relation.referencesTengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Wenstein MC, et al . Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15:369-90.spa
dc.relation.referencesKopans DB, Moore RH, McCarthy KA, Hall DA, Hulka CA, Whitman GJ, et al. Positive predictive value of breast biopsy performed as a result de mammography: there is not abrup change at age 50 years. Radiology 1996;200:357-60.spa
dc.relation.referencesSickles EA. Breast cancer screening outomes in women ages 40-49: clinical experience with service screening using modern mammography. Monogr Natl Cancer Inst 1997;22:99-104.spa
dc.relation.referencesCurpen BN, Sickles EA, Sollito RA, Ominsky SH, Galvin HB, Frankel SD. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR Am J Roentgenol 1995;164:1099-103.spa
dc.relation.referencesHeimann R, Bradley J, Hellman S. The benefits of mammography are not limited to women of ages older than 50 years. Cancer 1998;82:2221-6.spa
dc.relation.referencesMaibenco D, Dauod Y, Phillips E, Saxe A. Relationship betwen method of detection of breast cancer and stage of disease, method of treatment and survival in women aged 40-49 years. Am Surg 1999;65:1061-6.spa
dc.relation.referencesRosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183.134 screening mammograms in Alburquerque, New Mexico. Radiology 1998;209:511-8.spa
dc.relation.referencesErnster VA, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. Monogr Natl Cancer Inst 1997;22:151-6.spa
dc.relation.referencesEvans WP, Starr AL, Bennos ES. Comparison of the relative incidente of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 1997;204:489-91.spa
dc.relation.referencesTabar L, Faberberg G, Day NE, Holmberg. What is the optimum inteval betwen mammographic screening examinations? an analysis based on the latest results of the Swedish two-country breast cancer screening trial. Br J Cancer 1987;55:547-51.spa
dc.relation.referencesTabar L, Fagerberg G, Chen H-H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75:2507-17.spa
dc.relation.referencesKerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-8.spa
dc.relation.referencesMoss S.A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40.Trial Steering Group. J Med Screen 1999;6:144-148.spa
dc.relation.referenceshttp://www.saludcolombia.com/actual/htmlnormas/Res412_00.htm.spa
dc.relation.referencesWild JJ, Neal D. The use of high frequency ultrasonic waves for detecting changes of texture in living tisúes. Lancet 1951;1:655-657.spa
dc.relation.referencesRomero J, Aguirre D. BI-RADS en el informe ecográfico. Rev Col Radiol 2003;14(1):1325-1332.spa
dc.relation.referencesAmerican College of Radiology. Standard for the perfomance of the breast US examination. Reston VA. ACR 2002.spa
dc.relation.referencesSmith DN. Breast Ultrasound. Radiol Clin N Am 2001;39:485-497. 154. Metha TS. Current uses of ultrasound in the evaluation of the breast. Radiol Clin N Am 2003;41:841-856.spa
dc.relation.referencesGordon PB. Ultrasound for breast cancer screening and staging. Radiol Clin N Am 2002;40:431-441.spa
dc.relation.referencesBaker JA, Kornguth PJ, Soo MS, Walsk R y Mengoni P. Sonography of solid breast lesions: observer variability of lesion description and assessment. Am J Roentgenol 1999;172:1621-1625.spa
dc.relation.referencesBosh AM, Kessels AGH et al. Interexamination variation of whole breast ultrasound. Br J Radiol 2003;328-331.spa
dc.relation.referencesIkeda DM. Ecografía mamaria. En: Los Requisitos. Radiología de la mama. Edición en español. Ikeda DM Ed Elsevier Mosby Madrid; 2005 pp. 131-160.spa
dc.relation.referencesHilton SW, Leopold GR, Olson LK, Wilson SA. Real-time breast Sonography; application in 300 consecutive patients. Am J Roentgenol 1984;147:479-486.spa
dc.relation.referencesCiatto S, Cariaggi P, Bulgaresi P. The value of routine cytologic examination of breast cyst fluids. Acta Cytol 1987;31:301-304.spa
dc.relation.referencesBerg WA. Breast Ultrasonography: Cystic lesions and probable benign findings. In Women´s Imaging: categorical course syllabus. Leesburg VA. American Roentgen Ray Society 2004;95-101.spa
dc.relation.referencesVenta LA. Management of complex breast cysts. Am J Roentgenol 1999; 173: 1331-1336.spa
dc.relation.referencesKolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US—diagnostic yield and tumor characteristics. Radiology 1998;207:191-199.spa
dc.relation.referencesPalmer JR, Rosemberg L, Rao RS et al. Induced and spontaneous abortion in relation to risk of breast cancer (United States). Cancer Causes Control 1997;8:841-849.spa
dc.relation.referencesBerg WA. Cystic lesions of the breast: Sonographic- Pathologic correlation. Radiology 2003; 227: 183-191.spa
dc.relation.referencesVelasquez MV. Manejo de las lesiones quísticas complejas de seno. (Conferencia). Curso de Imágenes de la mujer. Fundación Santafé de Bogotá COL. 2003.spa
dc.relation.referencesBerg WA. Can clusters of microcyst appropriately be followed? (abstr). Radiology 2002;224:1375-1379.spa
dc.relation.referencesMercado CL, Harmele-Bena D, Sinbger C et al. Papillary lesions of the breast: evaluation with stereotactic direccional vacuum-assisted biopsy. Radiology 2001;221:650-655.spa
dc.relation.referencesStavros AT, Thickman D, Rapp CL, Dennos MA, Parker SH, Sisney GA. Solid breast nodules: use of Sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-134.spa
dc.relation.referencesLiberman L, Menell JH. BIRADS. Radiol Clin N Am 2002;40:409-430.spa
dc.relation.referencesSickles EA. Probable benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?. Radiology 1999;213:11-14.spa
dc.relation.referencesRahbar G, Sie AC, Hansen GC, Prince JS, Melany ML, Reynolds HE et al. Benign versus malignant solid breast masses: US differentiation. Radiology 1999;213:889-894.spa
dc.relation.referencesDennis MA, Parker SH, Klauss AJ, Stavros AT et al. Breast Biopsy Avoidance: The Value of Normal Mammograms and Normal Sonograms in the Setting of a Palpable Lump. Radiology 2001; 219:186–191.spa
dc.relation.referencesVignal P, Meslet MR, Romeo JM, Feuilhade F. Sonographic morphology of infiltrating breast carcinoma J Ultrasound med 2002;21:531-538.spa
dc.relation.referencesSickles EA, Herzog KA. Intramammary scar tissue: a mimic of the mammographic appearance of carcinoma. AJR 1980;135:349–352spa
dc.relation.referencesSickles EA, Herzog KA. Mammography of the post-surgical breast. AJR 1981 ;136:585–588spa
dc.relation.referencesHomer MJ. Mammographic appearance of the breast after needle localization and biopsy. Breast 1985 ;2:26–31spa
dc.relation.referencesDershaw DD, Shank B, Reisinger S. Mammographic findings after breast cancer treatment with local excision and definitive irradiation. Radiology 1987 ;164:455–461spa
dc.relation.referencesBrenner RJ, Pfaff JM. Mammographic features after conservation therapy for malignant breast disease: serial findings standardized by regression analysis. AJR 1996 ;167:171–178spa
dc.relation.referencesBrenner RJ, Pfaff JM. Mammographic changes after excisional breast biopsy for benign disease. AJR 1996;167:1047–1052spa
dc.relation.referencesLamm RL, Jackman RJ. Mammographic abnormalities caused by percutaneus stereotactic biopsy of histologically benign lesions evident on follow –up mammograms. AJR 2000;174:753–756spa
dc.relation.referencesMcDonald S, Saslow D and. Alciati MH. Performance and Reporting of Clinical Breast Examination: A Review of the Literature. CA Cancer J Clin 2004;54;345-361spa
dc.relation.referencesStavros, A T. Breast Ultrasound, eds. Lippincott Williams & Wilkins, 2006: 1-15.spa
dc.relation.referencesWorld Cancer Report IARC. Stewart BW, Kleihues P, editors. 188-219. 2003spa
dc.relation.referencesPardo C, Murillo R, Piñeros M, Castro MA. Casos nuevos de cáncer en el Instituto Nacional de Cancerología, Colombia, 2002. Rev Colomb Cancerol 2003; 7(3):4-19.spa
dc.contributor.cvlacRey Serrano, Juan José [0000265306]spa
dc.contributor.cvlacJaramillo Botero, Natalia [0001361289]spa
dc.contributor.cvlacMantilla Suárez, Juan Carlos [0001482827]spa
dc.contributor.googlescholarRey Serrano, Juan José [es&oi=ao]spa
dc.contributor.orcidRey Serrano, Juan José [0000-0002-6946-2444]spa
dc.contributor.orcidJaramillo Botero, Natalia [0000-0002-0126-1013]spa
dc.contributor.orcidMantilla Suárez, Juan Carlos [0000-0003-0201-0598]spa
dc.contributor.scopusRey Serrano, Juan José [54793298100]spa
dc.contributor.researchgateJaramillo Botero, Natalia [Natalia-Jaramillo-Botero-2187679037]
dc.subject.lembRadiodiagnósticospa
dc.subject.lembMamografíaspa
dc.subject.lembMedicinaspa
dc.subject.lembRadiologíaspa
dc.subject.lembImágenes diagnósticasspa
dc.subject.lembDiagnóstico por imagenspa
dc.subject.lembRadiografíasspa
dc.subject.lembInvestigacionesspa
dc.subject.lembAnálisisspa
dc.description.abstractenglishBreast cancer is the most common invasive tumor in women, with more than one million cases and nearly 600,000 deaths a year worldwide1 , with fees higher incidence in industrialized countries, such as the United States, Australia and Western European countries, which may be related to changes in reproductive patterns as well as greater use of mammogram 2 3 4 5 . The incidence rate is not the same for all racial groups and ethnic, reflecting the varying degrees of socioeconomic development and Cultural characteristics . Mammography is the only screening method that has shown a reduction in mortality rate due to breast cancer, and in the review of 8 studies randomized controlled mammography and 2 self-examination, performed by Jatoi, a 22% reduction in the death rate from cancer of breastfeed in women 50 years of age or older, during 14 years of observation, and than 15% in women between 40 and 49 years of age. The decrease in the rates of mortality was almost entirely attributable to the reduction in the distribution of size of cancers detected through screening mammography . He The main purpose of mammography is to detect cancer early, whenis small, node-negative and requires less intense treatment andhas a better prognosis.eng
dc.subject.proposalTumorspa
dc.subject.proposalPaíses industrializadosspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.description.learningmodalityModalidad Presencialspa


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 2.5 Colombia